Filing Details

Accession Number:
0001209191-21-018815
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-09 06:00:16
Reporting Period:
2021-03-08
Accepted Time:
2021-03-09 06:00:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1394319 Tracon Pharmaceuticals Inc. TCON Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1789822 B. Scott Brown C/O Tracon Pharmaceuticals, Inc.
4350 La Jolla Village Drive, Suite 800
San Diego CA 92122
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-08 1,000 $8.30 3,128 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.28 to $8.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
  2. Includes 350 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on each of April 20, 2020 and October 20, 2020.